211 related articles for article (PubMed ID: 25090458)
1. CYP1A2*1D and *1F polymorphisms have a significant impact on olanzapine serum concentrations.
Czerwensky F; Leucht S; Steimer W
Ther Drug Monit; 2015 Apr; 37(2):152-60. PubMed ID: 25090458
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.
Laika B; Leucht S; Heres S; Schneider H; Steimer W
Pharmacogenomics J; 2010 Feb; 10(1):20-9. PubMed ID: 19636338
[TBL] [Abstract][Full Text] [Related]
3. The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients.
Kootstra-Ros JE; Smallegoor W; van der Weide J
Ann Clin Biochem; 2005 May; 42(Pt 3):216-9. PubMed ID: 15949157
[TBL] [Abstract][Full Text] [Related]
4. Impact of CYP1A2 genetic polymorphisms on pharmacokinetics of antipsychotic drugs: a systematic review and meta-analysis.
Na Takuathung M; Hanprasertpong N; Teekachunhatean S; Koonrungsesomboon N
Acta Psychiatr Scand; 2019 Jan; 139(1):15-25. PubMed ID: 30112761
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.
Ammar H; Chadli Z; Mhalla A; Khouadja S; Hannachi I; Alshaikheid M; Slama A; Ben Fredj N; Ben Fadhel N; Ben Romdhane H; Chaabane A; Boughattas NA; Gaha L; Zarrouk L; Aouam K
Pharmacogenomics J; 2021 Oct; 21(5):551-558. PubMed ID: 33731885
[TBL] [Abstract][Full Text] [Related]
6. ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
Jaquenoud Sirot E; Knezevic B; Morena GP; Harenberg S; Oneda B; Crettol S; Ansermot N; Baumann P; Eap CB
J Clin Psychopharmacol; 2009 Aug; 29(4):319-26. PubMed ID: 19593168
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoking and heavy coffee consumption affecting response to olanzapine: The role of genetic polymorphism.
Djordjevic N; Radmanovic B; Cukic J; Baskic D; Djukic-Dejanovic S; Milovanovic D; Aklillu E
World J Biol Psychiatry; 2020 Jan; 21(1):29-52. PubMed ID: 30513034
[No Abstract] [Full Text] [Related]
8. The CYP1A2 -163C>A polymorphism is associated with clozapine-induced generalized tonic-clonic seizures in Brazilian schizophrenia patients.
Kohlrausch FB; Severino-Gama C; Lobato MI; Belmonte-de-Abreu P; Carracedo A; Hutz MH
Psychiatry Res; 2013 Sep; 209(2):242-5. PubMed ID: 23601795
[TBL] [Abstract][Full Text] [Related]
9. The relationship between the response of clinical symptoms and plasma olanzapine concentration, based on pharmacogenetics: Juntendo University Schizophrenia Projects (JUSP).
Nozawa M; Ohnuma T; Matsubara Y; Sakai Y; Hatano T; Hanzawa R; Shibata N; Arai H
Ther Drug Monit; 2008 Feb; 30(1):35-40. PubMed ID: 18223460
[TBL] [Abstract][Full Text] [Related]
10. Association of a functional polymorphism in neuropeptide Y with antipsychotic-induced weight gain in schizophrenia patients.
Tiwari AK; Brandl EJ; Weber C; Likhodi O; Zai CC; Hahn MK; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
J Clin Psychopharmacol; 2013 Feb; 33(1):11-7. PubMed ID: 23277265
[TBL] [Abstract][Full Text] [Related]
11. Impact of CYP1A2 and CYP2D6 polymorphisms on drug metabolism and on insulin and lipid elevations and insulin resistance in clozapine-treated patients.
Melkersson KI; Scordo MG; Gunes A; Dahl ML
J Clin Psychiatry; 2007 May; 68(5):697-704. PubMed ID: 17503978
[TBL] [Abstract][Full Text] [Related]
12. Contributions of cholinergic receptor muscarinic 1 and CYP1A2 gene variants on the effects of plasma ratio of clozapine/N-desmethylclozapine on working memory in schizophrenia.
Islam F; Maciukiewicz M; Freeman N; Huang E; Tiwari A; Mulsant BH; Pollock BG; Remington G; Kennedy JL; Müller DJ; Rajji TK
J Psychopharmacol; 2021 Jan; 35(1):31-39. PubMed ID: 33143542
[TBL] [Abstract][Full Text] [Related]
13. Carriers of the UGT1A4 142T>G gene variant are predisposed to reduced olanzapine exposure--an impact similar to male gender or smoking in schizophrenic patients.
Ghotbi R; Mannheimer B; Aklillu E; Suda A; Bertilsson L; Eliasson E; Osby U
Eur J Clin Pharmacol; 2010 May; 66(5):465-74. PubMed ID: 20143052
[TBL] [Abstract][Full Text] [Related]
14. Development of asymptomatic pancreatitis with paradoxically high serum clozapine levels in a patient with schizophrenia and the CYP1A2*1F/1F genotype.
Sani G; Kotzalidis GD; Simonetti A; Solfanelli A; Mancinelli I; Calabrò G; De Rossi P; De Luca O; Gentile G; Lionetto L; Manfredi G; Girardi N; Ambrosi E; Simmaco M; Tatarelli R
J Clin Psychopharmacol; 2010 Dec; 30(6):737-9. PubMed ID: 21057239
[No Abstract] [Full Text] [Related]
15. Association between CYP1A2 polymorphisms and clozapine-induced adverse reactions in patients with schizophrenia.
Ferrari M; Bolla E; Bortolaso P; Callegari C; Poloni N; Lecchini S; Vender S; Marino F; Cosentino M
Psychiatry Res; 2012 Dec; 200(2-3):1014-7. PubMed ID: 22901441
[TBL] [Abstract][Full Text] [Related]
16. The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement.
van der Weide J; Steijns LS; van Weelden MJ
Pharmacogenetics; 2003 Mar; 13(3):169-72. PubMed ID: 12618594
[TBL] [Abstract][Full Text] [Related]
17. The association of genetic polymorphisms in CYP1A2, UGT1A4, and ABCB1 with autonomic nervous system dysfunction in schizophrenia patients treated with olanzapine.
Hattori S; Suda A; Miyauchi M; Shiraishi Y; Saeki T; Fukushima T; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Moritani T; Saigusa Y; Kishida I
BMC Psychiatry; 2020 Feb; 20(1):72. PubMed ID: 32070304
[TBL] [Abstract][Full Text] [Related]
18. The effect of variable cigarette consumption on the interaction with clozapine and olanzapine.
Haslemo T; Eikeseth PH; Tanum L; Molden E; Refsum H
Eur J Clin Pharmacol; 2006 Dec; 62(12):1049-53. PubMed ID: 17089108
[TBL] [Abstract][Full Text] [Related]
19. Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.
Bondolfi G; Morel F; Crettol S; Rachid F; Baumann P; Eap CB
Ther Drug Monit; 2005 Aug; 27(4):539-43. PubMed ID: 16044115
[TBL] [Abstract][Full Text] [Related]
20. The effect of CYP1A2 gene polymorphisms on Theophylline metabolism and chronic obstructive pulmonary disease in Turkish patients.
Uslu A; Ogus C; Ozdemir T; Bilgen T; Tosun O; Keser I
BMB Rep; 2010 Aug; 43(8):530-4. PubMed ID: 20797314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
